NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
2 hedge funds and large institutions have $661K invested in NRX Pharmaceuticals Warrant in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 11 closing their positions.
5% more capital invested
Capital invested by funds: $632K → $661K (+$29K)
85% less funds holding
Funds holding: 13 → 2 (-11)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$365K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$95K |
| 3 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$46.9K |
| 4 |
VAS
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
|
-$42K |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AQR Arbitrage
Greenwich,
Connecticut
| $470K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $191K | -$46.9K | -41,800 | -51% |
|
|
PAMP
3
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$95K | -366,000 | Closed |
|
|
VAS
4
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
| – | -$42K | -160,379 | Closed |
|
|
RCM
5
Rivernorth Capital Management
West Palm Beach,
Florida
| – | -$31K | -118,662 | Closed |
|
|
6CM
6
683 Capital Management
New York
| – | -$21K | -82,500 | Closed |
|
|
GCL
7
Glazer Capital LLC
New York
| – | -$17K | -66,710 | Closed |
|
|
BFM
8
Boothbay Fund Management
New York
| – | -$365K | -34,063 | Closed |
|
9
Walleye Trading
New York
| – | -$5K | -20,000 | Closed |
|
|
HF
10
HRT Financial
New York
| – | -$3K | -12,979 | Closed |
|
|
LIM
11
Longfellow Investment Management
Boston,
Massachusetts
| – | -$3K | -11,300 | Closed |
|
|
HIM
12
HGC Investment Management
Toronto,
Ontario, Canada
| – | -$2K | -5,503 | Closed |
|
13
UBS Group
Zurich,
Switzerland
| – | -$1K | -3,475 | Closed |
|
NRXPW Hedge Fund Activity: Q4 2020 in Review
2 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2020, worth a combined $661K — up 4.6% from $632K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NRXPW and 0 opened new positions — a net loss of 11 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $365K sold.
- 2 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2020, down from 13 in Q3 2020.
- Funds reported $661K of NRX Pharmaceuticals Warrant stock for Q4 2020, up 4.6% quarter-over-quarter.
- 0 funds opened new NRX Pharmaceuticals Warrant positions in Q4 2020 and 11 closed out, a net change of -11 holders.
- The largest NRX Pharmaceuticals Warrant seller in Q4 2020 was Boothbay Fund Management, an estimated $365K sold.
Based on aggregated 13F filings for Q4 2020.